grants_govRFA-RM-27-001
Open
NIH Director’s Pioneer Award (DP1 Clinical Trial Optional)
- Response deadline
- Sep 9, 2026 Closed
- Date posted
- Jun 29, 2026
- Source
- Open notice
Description
The NIH Director"s Pioneer Award supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator"s research program or elsewhere. Applications in all topics relevant to the broad mission of NIH are welcome. Research may involve basic, translational, or clinical research. The NIH Director"s Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.
Classifications
- NAICS93.310
Documents (1)
- RFA-RM-27-001-Full-Announcement.htmltext/html;charset=UTF-8135 KBNot yet available
Contacts
Similar contracts
- Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)Due Jan 8, 2027
- Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)Due Jan 8, 2027
- Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed)Due Jan 8, 2027
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)Due Jan 29, 2027
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)Due Nov 23, 2026
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)Due Nov 23, 2026